CO.DON AG / Key word(s): Market launch
CO.DON AG: CO.DON AG signs term sheet with Haemo Pharma GmbH for the distribution of Spherox in Austria
12-Jun-2018 / 18:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
CO.DON AG (ISIN: DE DE000A1K0227)
CO.DON AG signs term sheet with Haemo Pharma GmbH for the distribution of Spherox in Austria
Berlin / Teltow, 12 June 2018 – CO.DON AG is in final stage negotiations with Haemo Pharma GmbH concerning the exclusive distribution in Austria of Spherox, a cell-based pharmaceutical for which central EU marketing authorisation has been granted. The parties signed a term sheet today governing the key elements of their potential collaboration and of a distribution agreement, which now has to be refined in detail. By signing the distribution agreement, with an initial term of 5 years, CO.DON AG would generate at least a guaranteed cash inflow in the first two years of (all in all) approximately 17% of the revenue in the financial year 2017 (revenue in 2017: kEUR 5,964). From 2020, cash inflow will depend on the development of the state reimbursement situation. The distribution agreement is subject to the approval of the Supervisory Board of CO.DON AG.
12-Jun-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange|
|End of Announcement||DGAP News Service|